Verastem | VSTM - Trade Debtors


Verastem reported $200K in Trade Debtors for its fiscal quarter ending in September of 2024.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Curis USD 2.55M 400K Jun/2024
Cytokinetics USD 1.81M 6.6M Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Laboratory Of America USD 2.26B 4.5M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Roche Holding CHF 11.9B 460M Dec/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025
Verastem USD 200K 10.72M Sep/2024